These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28785925)

  • 21. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.
    Wehkamp U; Oschlies I; Nagel I; Brasch J; Kneba M; Günther A; Klapper W; Weichenthal M
    J Cutan Pathol; 2015 Nov; 42(11):870-7. PubMed ID: 26053561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cogent data on allogeneic haematopoietic stem-cell transplantation efficacy in advanced cutaneous T-cell lymphoma.
    Iqbal M; Kharfan-Dabaja MA
    Lancet; 2023 Jun; 401(10392):1906-1907. PubMed ID: 37105211
    [No Abstract]   [Full Text] [Related]  

  • 24. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study.
    Martino R; Giralt S; Caballero MD; Mackinnon S; Corradini P; Fernández-Avilés F; San Miguel J; Sierra J
    Haematologica; 2003 May; 88(5):555-60. PubMed ID: 12745275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
    J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic haematopoietic stem cell transplantation in a patient with cutaneous γ/δ-T-cell lymphoma.
    Terras S; Moritz RK; Ditschkowski M; Beelen DW; Altmeyer P; Stücker M; Kreuter A
    Acta Derm Venereol; 2013 May; 93(3):360-1. PubMed ID: 23007198
    [No Abstract]   [Full Text] [Related]  

  • 27. Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: a systematic review.
    Schlaak M; Theurich S; Pickenhain J; Skoetz N; Kurschat P; von Bergwelt-Baildon M
    Crit Rev Oncol Hematol; 2013 Jan; 85(1):21-31. PubMed ID: 22819279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
    Yamasaki S; Suzuki R; Hatano K; Fukushima K; Iida H; Morishima S; Suehiro Y; Fukuda T; Uchida N; Uchiyama H; Ikeda H; Yokota A; Tsukasaki K; Yamaguchi H; Kuroda J; Nakamae H; Adachi Y; Matsuoka KI; Nakamura Y; Atsuta Y; Suzumiya J
    Bone Marrow Transplant; 2017 Jul; 52(7):969-976. PubMed ID: 28368379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
    Glass B; Hasenkamp J; Wulf G; Dreger P; Pfreundschuh M; Gramatzki M; Silling G; Wilhelm C; Zeis M; Görlitz A; Pfeiffer S; Hilgers R; Truemper L; Schmitz N;
    Lancet Oncol; 2014 Jun; 15(7):757-66. PubMed ID: 24827808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
    Duarte RF; Schmitz N; Servitje O; Sureda A
    Bone Marrow Transplant; 2008 Apr; 41(7):597-604. PubMed ID: 18176611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
    Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
    Bagot M; Hasan B; Whittaker S; Beylot-Barry M; Knobler R; Shah E; Marreaud S; Morris S; Dalle S; Servitje O; Cowan R; Väkevä L; Chaby G; Jonak C; Fox CP; Ritchie D; Vermeer MH; Stadler R; Romero PLO; Scarisbrick J; Quaglino P
    Eur J Dermatol; 2017 Jun; 27(3):286-294. PubMed ID: 28468739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
    Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
    Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma.
    Väkevä L; Niittyvuopio R; Leppä S; Heiskanen J; Lindström V; Ranki A; Volin L
    Acta Derm Venereol; 2016 Aug; 96(6):816-7. PubMed ID: 26864630
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathology findings in patients with cutaneous T-cell lymphomas treated with allogeneic haematopoietic stem cell transplantation.
    Menter T; Medani H; Olavarria E; Kanfer E; Naresh KN
    Br J Haematol; 2018 Mar; 180(6):904-908. PubMed ID: 27984647
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of rare cutaneous T‑cell lymphoma and blastic plasmacytoid dendritic cell neoplasm].
    Wehkamp U; Weichenthal M
    Hautarzt; 2017 Sep; 68(9):711-715. PubMed ID: 28795194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.
    Virmani P; Zain J; Rosen ST; Myskowski PL; Querfeld C
    Dermatol Clin; 2015 Oct; 33(4):807-18. PubMed ID: 26433851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas.
    Dumont M; Peffault de Latour R; Ram-Wolff C; Bagot M; de Masson A
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.
    Herbert KE; Spencer A; Grigg A; Ryan G; McCormack C; Prince HM
    Bone Marrow Transplant; 2004 Sep; 34(6):521-5. PubMed ID: 15286686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.